Tiracizine HCl

Tiracizine HCl is a Class I antiarrhythmic agent studied in models of ischemic heart disease, where it demonstrates a negative inotropic effect by reducing myocardial contractility. It is utilized in cardiovascular research to investigate arrhythmia mechanisms and cardiac function in both in vitro and in vivo experimental settings.